Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This study aims to develop and validate nomograms for predicting the risk of aneurysm rupture and adverse prognosis in patients with Moyamoya disease (MMD) and associated intracranial aneurysms (IAs). We analyzed 286 saccular and 22 non-saccular IAs from 231 MMD patients. We used logistic regression to identify risk factors for IA rupture and Cox regression to find factors associated with prognosis. Nomograms were constructed using R 4.3.3 software based on these risk factors and validated via receiver operating characteristic (ROC) curves, calibration curves, and clinical decision curves. Among 3293 MMD patients, 231 (7.01%) harbored IAs. Saccular IAs had a higher rupture rate (24.2%) compared to non-saccular IAs (13.64%). Independent risk factors for rupture in non-saccular IAs included the presence of a daughter sac, whereas the location, flow angle, and aspect ratiowere risk factors for saccular IA rupture. Prognostic factors included rerupture and modified Fisher scale. The constructed nomograms demonstrated robust predictive performance in the validation cohort. Our nomograms effectively predict the risk of rupture in saccular IAsand poor prognosis in MMD patients with IAs, offering valuable tools for clinical decision-making.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12271559PMC
http://dx.doi.org/10.1038/s41598-025-97255-1DOI Listing

Publication Analysis

Top Keywords

risk factors
16
non-saccular ias
12
mmd patients
12
aneurysm rupture
8
moyamoya disease
8
intracranial aneurysms
8
factors rupture
8
rupture
7
risk
7
ias
7

Similar Publications

Major ABO-Incompatible Platelet Transfusions Are Associated With Brain Ischemia After Intracerebral Hemorrhage.

Stroke

September 2025

Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York. (F.C.P., M.R., M.S., A.K., S.G., S.A., S.P., J.C., D.J.R.).

Background: Major ABO-incompatible platelet transfusions are associated with poor intracerebral hemorrhage (ICH) outcomes, yet drivers for this relationship remain unclear. Brain magnetic resonance imaging (MRI) ischemic lesions after ICH are neuroimaging biomarkers of secondary brain injury and are associated with poor outcomes. Given that ABO-incompatible platelet transfusions can induce immune complex formation, thrombo-inflammation, and endothelial barrier disruption, factors that could exacerbate cerebral ischemia, we explored whether major ABO-incompatible platelet transfusions are risk factors for ischemic lesions on brain MRI after ICH.

View Article and Find Full Text PDF

In-Flight Deterioration Occurs Early in Aeromedical Trauma Patients.

Emerg Med Australas

October 2025

Australian Centre for Health Services Innovation, School of Public Health & Social Work, Queensland University of Technology, Brisbane, Queensland, Australia.

Reliably defining the risk of adverse in-flight events in aeromedical trauma patients could enable more informed pre-departure treatment and guide central asset allocation to achieve better system-level outcomes. Unfortunately, the current literature base specifically examining the in-flight period is sparse. Flight duration is often considered a proxy for the risk of in-flight deterioration; however, there is limited data to support this commonly held assumption.

View Article and Find Full Text PDF

Background: Cardio-kidney-metabolic (CKM) disease represents a significant public health challenge. While proteomics-based risk scores (ProtRS) enhance cardiovascular risk prediction, their utility in improving risk prediction for a composite CKM outcome beyond traditional risk factors remains unknown.

Methods: We analyzed 23 815 UK Biobank participants without baseline CKM disease, defined by -Tenth Revision codes as cardiovascular disease (coronary artery disease, heart failure, stroke, peripheral arterial disease, atrial fibrillation/flutter), kidney disease (chronic kidney disease or end-stage renal disease), or metabolic disease (type 2 diabetes or obesity).

View Article and Find Full Text PDF

Anxiety disorders are the most prevalent mental illness in Australia and are more common in women relative to men, as well as transgender and gender diverse people relative to cisgender people. Sex and gender differences in anxiety prevalence are likely driven by a combination of factors including differential exposure to different types of stressors and trauma, gendered enculturation of different coping responses and perceived stigma of mental illness, differences in medical comorbidities, and differences in symptom presentations. The established impact of gonadal hormone changes on anxiety risk and symptom presentation across the female lifespan underscore the need for sex- and gender-responsive management of anxiety disorders.

View Article and Find Full Text PDF

Background: Genetic variation contributes to atrial fibrillation (AF), but its impact may vary with age. The Research Program contains whole-genome sequencing of data from 100 574 adult participants with linked electronic health records.

Methods: We assessed clinical, monogenic, and polygenic associations with AF in a cross-sectional analysis, stratified by age: <45 years (n=22 290), 45 to 60 years (n=26 805), and >60 years (n=51 659).

View Article and Find Full Text PDF